Vor Biopharma Inc (VOR)
1.81
+0.01
(+0.56%)
USD |
NASDAQ |
May 17, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Cash from Operations (Quarterly): -30.46M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -30.46M |
| December 31, 2023 | -24.03M |
| September 30, 2023 | -27.90M |
| June 30, 2023 | -24.10M |
| March 31, 2023 | -24.27M |
| December 31, 2022 | -18.35M |
| September 30, 2022 | -18.90M |
| June 30, 2022 | -24.99M |
| March 31, 2022 | -22.90M |
| Date | Value |
|---|---|
| December 31, 2021 | -17.59M |
| September 30, 2021 | -17.34M |
| June 30, 2021 | -16.56M |
| March 31, 2021 | -17.65M |
| December 31, 2020 | -13.63M |
| September 30, 2020 | -8.245M |
| June 30, 2020 | -8.328M |
| March 31, 2020 | -6.085M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-30.46M
Minimum
Mar 2024
-6.085M
Maximum
Mar 2020
-18.90M
Average
-18.35M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Masimo Corp | 45.80M |
| AnaptysBio Inc | -37.25M |
| Apellis Pharmaceuticals Inc | -132.98M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 43.97M |
| Cash from Financing (Quarterly) | 0.096M |
| Free Cash Flow | -107.58M |
| Free Cash Flow Per Share (Quarterly) | -0.4495 |
| Free Cash Flow Yield | -87.88% |